Janney Montgomery Scott Upgrades EPR Props to Buy
Janney Montgomery Scott analyst Robert Stevenson upgrades EPR Props (NYSE:EPR) from Neutral to Buy.
Oppenheimer Maintains Outperform on Shopify. Price adjusts to $50.
Oppenheimer analyst Brian Schwartz maintains Shopify (NYSE:SHOP) with a Outperform. Price adjusts to $50
Fisker Announces Fisker Finance, Providing Seamless Financing Options For Customers; Reaffirms Nomination of Retail Financing Partners
Digital financing program aligns with launch of Fisker Ocean in November 2022
Fisker reaffirms nomination of Chase in the US and Santander Consumer Finance in Europe as Fisker's retail financing partners, with
BitNile Holdings’ Subsidiary Ault Alliance Does Not Acquire EYP; Loan To EYP Repaid In Full, Including $2.9M Break-up Fee And Partial Expense Reimbursement
BitNile Holdings, Inc. (NYSE:NILE), a diversified holding company ("BitNile" or the "Company") announced today that its subsidiary, Ault Alliance, Inc. ("Ault Alliance"), did not
Barclays Maintains Overweight on Eli Lilly, Raises Price Target to $355
Barclays analyst Geoff Meacham maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $333 to $355.
Credit Suisse Maintains Neutral on MarketAxess Holdings, Lowers Price Target to $305
Credit Suisse analyst Gautam Sawant maintains MarketAxess Holdings (NASDAQ:MKTX) with a Neutral and lowers the price target from $316 to $305.
Why Is GameStop Surging By Around 10%? 22 Stocks Moving In Thursday’s Pre-Market Session
Gainers
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 39.6% to $0.2471 in pre-market trading after declining over 8% on Wednesday. Allena Pharmaceuticals recently announced rescheduling of special meeting to approve reverse stock split.
HC Wainwright & Co. Maintains Buy on Gold Royalty, Raises Price Target to $8.5
HC Wainwright & Co. analyst Heiko Ihle maintains Gold Royalty (AMEX:GROY) with a Buy and raises the price target from $8.25 to $8.5.
UBS Downgrades Kellogg to Neutral, Lowers Price Target to $74
UBS analyst Cody Ross downgrades Kellogg (NYSE:K) from Buy to Neutral and lowers the price target from $81 to $74.